Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Short-term Investments (2019 - 2025)

STRATA Skin Sciences' Short-term Investments history spans 7 years, with the latest figure at $1.3 million for Q1 2025.

  • On a quarterly basis, Short-term Investments changed 0.0% to $1.3 million in Q1 2025 year-over-year; TTM through Mar 2025 was $1.3 million, a 0.0% change, with the full-year FY2024 number at $1.3 million, changed 0.0% from a year prior.
  • Short-term Investments hit $1.3 million in Q1 2025 for STRATA Skin Sciences, roughly flat from $1.3 million in the prior quarter.
  • Over the last five years, Short-term Investments for SSKN hit a ceiling of $7.5 million in Q1 2021 and a floor of $1.3 million in Q3 2023.
  • Historically, Short-term Investments has averaged $2.3 million across 5 years, with a median of $1.3 million in 2023.
  • Biggest five-year swings in Short-term Investments: grew 0.81% in 2021 and later dropped 1.98% in 2023.
  • Tracing SSKN's Short-term Investments over 5 years: stood at $7.5 million in 2021, then plummeted by 81.75% to $1.4 million in 2022, then fell by 1.98% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then changed by 0.0% to $1.3 million in 2025.
  • Business Quant data shows Short-term Investments for SSKN at $1.3 million in Q1 2025, $1.3 million in Q4 2024, and $1.3 million in Q3 2024.